ONC

BeOne Medicines (ONC)

About BeOne Medicines (ONC)

BeOne Medicines Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Basel, Switzerland.

Details

Daily high

$305.82

Daily low

$299.50

Price at open

52 Week High

$385.22

52 Week Low

$170.99

Market cap

31.0B

Dividend yield

0.00%

Volume

Avg. volume

298,988

P/E ratio

585.44

BeOne Medicines News